Pluristem Therapeutics Inc (PSTI)

[Crustacener]

i did some calculation for fun:

With estimated 190.000 ARDS cases in the US and a mortality of approx. 75.000 - only to treat those 75.000 patients Pluristem would need approx. 63 Bioreactors of the old standard type (with 300 million cells per treatment). This would bring them a revenue of 1.5 Billion Dollars (20.000 Dollars per treatment?). Estimating a 15% profit margin this would equal a profit per shar of 10 Dollars.

With a P/E of lets say 60? this is 590 Dollars per share.

Where is my mistake? Is there one?

Your thoughts...